Posted by Michael Wonder on 09 Sep 2019
Novo Nordisk launching additional US insulin affordability offerings in January 2020
6 September 2019 - $99 Cash Card Program provides 3,000 - 3,600 units of any combination of Novo Nordisk analog insulins in vials or pens from Novo Nordisk.
Novo Nordisk is expanding the company's affordability offering in the US beginning January 2, 2020. People with diabetes experience different issues and complexities that can't be covered by one solution.
That's why the company continues to bring forth programs that will directly benefit even more people with diabetes – including those with insurance and those without – as we work toward much needed longer-term systemic reform.
